The impact of the boxed warning on the duration of use for depot medroxprogesterone acetate.

about

Measuring the impact of medicines regulatory interventions - Systematic review and methodological considerations.

P2860

Q47653552-831940D5-D546-497F-932B-830A3E9A1D65

P2860

The impact of the boxed warning on the duration of use for depot medroxprogesterone acetate.

Item

http://www.wikidata.org/entity/Q38764193

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

The impact of the boxed warnin ...... ot medroxprogesterone acetate.

@en

type

Item

label

The impact of the boxed warnin ...... ot medroxprogesterone acetate.

@en

prefLabel

The impact of the boxed warnin ...... ot medroxprogesterone acetate.

@en

P1476

The impact of the boxed warnin ...... ot medroxprogesterone acetate.

@en

P2093

David G Moeny

http://www.w3.org/2001/XMLSchema#string

Joo-Yeon Lee

http://www.w3.org/2001/XMLSchema#string

Lisa Soule

http://www.w3.org/2001/XMLSchema#string

Vaishali Popat

http://www.w3.org/2001/XMLSchema#string

P2860

The association between depot medroxyprogesterone acetate contraception and bone mineral density in adolescent women.

Change in bone mineral density among adolescent women using and discontinuing depot medroxyprogesterone acetate contraception.

Depot medroxyprogesterone acetate and bone mineral density in adolescents--the Black Box Warning: a Position Paper of the Society for Adolescent Medicine.

Recovery of bone mineral density in adolescents following the use of depot medroxyprogesterone acetate contraceptive injections.

Magnitude and variability of sequential estradiol and progesterone concentrations in women using depot medroxyprogesterone acetate for contraception.

Bone mineral density in a cohort of adolescent women using depot medroxyprogesterone acetate for one to two years.

Bone mineral density in adolescent females using depot medroxyprogesterone acetate.

Bone mineral density changes over two years in first-time users of depot medroxyprogesterone acetate.

Depo-Provera and skeletal health: a survey of Florida obstetrics and gynecologist physicians.

Bone mineral density in women aged 25–35 years receiving depot medroxyprogesterone acetate: recovery following discontinuation

P304

827-836

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/PDS.4227

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

E Eworuke

P577

2017-05-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28543978

http://www.w3.org/2001/XMLSchema#string

The impact of the boxed warning on the duration of use for depot medroxprogesterone acetate.

about

P2860

P2860

The impact of the boxed warning on the duration of use for depot medroxprogesterone acetate.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698